BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alhosaini K, Azhar A, Alonazi A, Al-Zoghaibi F. GPCRs: The most promiscuous druggable receptor of the mankind. Saudi Pharm J 2021;29:539-51. [PMID: 34194261 DOI: 10.1016/j.jsps.2021.04.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu X, Zhang X, Liu Y, Gao M, Lin M, Xie Y, Zhu Q, Xu C, Liu X, Vosloo D, Pooe OJ. Generation of Human Domain Antibody Fragments as Potential Insecticidal Agents against Helicoverpa armigera by Cadherin-Based Screening. J Agric Food Chem 2022. [PMID: 35944165 DOI: 10.1021/acs.jafc.2c02000] [Reference Citation Analysis]
2 Kaneto H, Kimura T, Shimoda M, Obata A, Sanada J, Fushimi Y, Matsuoka T, Kaku K. Molecular Mechanism of Pancreatic β-Cell Failure in Type 2 Diabetes Mellitus. Biomedicines 2022;10:818. [DOI: 10.3390/biomedicines10040818] [Reference Citation Analysis]
3 Fatima MT, Ahmed I, Fakhro KA, Akil ASA. Melanocortin-4 receptor complexity in energy homeostasis,obesity and drug development strategies. Diabetes Obes Metab 2022;24:583-98. [PMID: 34882941 DOI: 10.1111/dom.14618] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Wiseman DN, Samra N, Román Lara MM, Penrice SC, Goddard AD. The Novel Application of Geometric Morphometrics with Principal Component Analysis to Existing G Protein-Coupled Receptor (GPCR) Structures. Pharmaceuticals (Basel) 2021;14:953. [PMID: 34681177 DOI: 10.3390/ph14100953] [Reference Citation Analysis]
5 Kaneto H, Kimura T, Shimoda M, Obata A, Sanada J, Fushimi Y, Nakanishi S, Mune T, Kaku K. Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: "The Earlier, the Better" in Therapy with Incretin-Based Medicine. Int J Mol Sci 2021;22:7917. [PMID: 34360682 DOI: 10.3390/ijms22157917] [Reference Citation Analysis]